IMMUNOHISTOCHEMISTRY, SYNAPTOPHYSIN

The IHC – Synaptophysin test is an immunohistochemistry-based diagnostic assay used to detect Synaptophysin protein expression in tissue samples. Synaptophysin is a membrane glycoprotein found in presynaptic vesicles of neurons and neuroendocrine cells, making it one of the most important markers for identifying neuroendocrine differentiation in tumors.

This test is widely used in pathology and oncology to diagnose and classify neuroendocrine tumors (NETs). Synaptophysin staining helps pathologists determine whether tumor cells originate from neuroendocrine tissue and assists in distinguishing neuroendocrine tumors from other types of cancer.

The IHC Synaptophysin test is commonly used in combination with other neuroendocrine markers such as Chromogranin A, CD56, NSE, and INSM1 to improve diagnostic accuracy. It is considered one of the most sensitive markers for neuroendocrine differentiation and is frequently included in tumor immunohistochemistry panels.

Benefits of the Test

• Helps diagnose neuroendocrine tumors
• Assists in identifying neuroendocrine differentiation
• Supports tumor classification and grading
• Improves diagnostic accuracy in oncology
• Helps guide treatment planning and prognosis evaluation

Why Doctors Recommend This Test

Doctors recommend the IHC Synaptophysin test when evaluating suspected neuroendocrine tumors and related cancers. It is commonly used in:

• Neuroendocrine tumor diagnosis
• Carcinoid tumor evaluation
• Small cell carcinoma assessment
• Pancreatic neuroendocrine tumor investigation
• Lung neuroendocrine tumor classification
• Tumor pathology and oncology studies

Synaptophysin is often evaluated alongside Chromogranin A, CD56, Ki-67, Cytokeratins, and NSE to provide a comprehensive neuroendocrine tumor profile.

Preparation Before Test

No special preparation is required for this test. Important considerations include:

• The test is performed on a biopsy or surgical tissue sample
• No fasting is required
• No medication restrictions are generally necessary
• Clinical history and imaging findings may assist interpretation

Normal Reporting Time

The typical turnaround time is 3 to 5 working days, depending on tissue processing and laboratory workflow.

Who Should Take This Test

• Patients with suspected neuroendocrine tumors
• Individuals undergoing cancer biopsy evaluation
• Patients with small cell carcinoma
• Cases requiring tumor origin determination
• Oncology patients requiring immunohistochemistry profiling

The IHC Synaptophysin test is an essential diagnostic tool in modern pathology. By detecting neuroendocrine differentiation, it helps clinicians accurately diagnose tumors, classify cancer subtypes, and develop effective treatment strategies.

Clinical Significance

Synaptophysin immunostaining is commonly used in the evaluation of:

• Neuroendocrine tumors (NETs)
• Carcinoid tumors
• Small cell lung carcinoma
• Pancreatic neuroendocrine tumors
• Neuroblastoma
• Pheochromocytoma
• Paraganglioma
• Neuroendocrine carcinomas

Strong Synaptophysin positivity is a key indicator of neuroendocrine differentiation and plays a vital role in tumor classification.